Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Pral4691g00105 | ATGGATCTTCTTCTGGGTCTTCTTCTTCTGGCCTTTGTCTTTCTCTTCACCGCCCATTGCTCAGAAGATATTGCTACTTCTGTCCCTAGTGACGCATTGTCCCTTCTCAGCTTCAAGGACTCCGTCTCTTCCGAATCTTCTGCCCTTCTCGTTGGATGGAGTAAGGAGTCTACTGAAAGTTACTGTCAATGGCACGGCGTTACCTGCGAGGATAGGCTCTCTGGCAGAGTTATTGCTTTGAACTTGACCGGACTTCGCGGCGGCAAGCTCACTCCTTCCATTGGAGATATGTCTGGGCTTCGAGTTTTGTCCCTTCCCCAAAATACGTTCTCCGGTGAGATCCCGGAGACTCTGGGGAAGCTTCGGCTTCTGGAGGTTCTTGAGCTTCAAGAAAACAATTTTTCCGGAGGGATCCCCAACCAGATAAGCTATCTTCCATCTCTTCGCATTCTTAACCTCTCTAATAATGCTTTGTCCGGTTCCATGCCTGGTAAATTGATTGGCTTTGGAAATGTTAGCGTCATGGACTTGTCGAGCAATCAGCTTTCTGGTCCAATTGTAGATAGCGTCAATACTGTCTTTGAATTTTTGAATCATTTGAAGCTGTCCGACAACTTCCTCACGGGCCAAATTCCGTCCGAAATTGGGAAATTCAGAAATCTGAGGACGCTTTTACTCGATGGGAATATCTTAGAAGGCGCTATCCCTTCTGAGATTGGGTATATGACGGAACTCAGACTTCTAGATGTCTCTAGAAATAGTCTTACTGGAAGAATTCCAAAAGAAATAGCCAACTGCCGGAAACTGTCAGTGCTTGTGTTGACTGATTTAGTCGATGATACTCCTTCTCCGGATGAGAGCTCGGTGAATAGCTTCAGAGGGGAATTCAATGCTTTTGTTGGAAATATTCCTCCGCAGGTAATGTTGCTCTCAAGTTTAGAGATTTTGTGGGCACCAAGAGCGAATCTTGGCGGACGGTTGCCTAGGGGCTGGACAGATTCATGCTCGCTGAGAGTAGTCAACTTGGCAGAGAATTATATTATTGGGGGGATACCAGAAACCTTAGGGATGTGCAGAAATTTAACTTTCCTTGACCTGAGCTCTAACAATTTAGTGGGGTATCTTCCTTTAAAGCAACTTCAAGTTCCATGTATGTTGTACTTCAATGTTAGCTGGAATAATTTATCTGGCACCCTTCCAGGATTTGGGAACGAAAGCTGTGATTTAAGCAGAATCCTAGGTGATGCACAAGTTGATATTCTTGTTTGGGAATCTCTGATGGATGCTCTCCCTGGATCAGGTTCAGAAGATGCTGTCGTCATTAACCATGATTTCAGTTGGAATAACTTTACGGGATCTTTACCTTTATTCTTACTGGGAGATACTACAAGGAGCAAGATTTCCTACACGCTATCACTCAGTAATAACAAGTTCAGTGGAACTCTACCATATCATCTGGTTTTGAACTGTAATGATTTCAAGATGTTAAAGGTTAACTTGAGTGTGAACGAACTCTCTGGTGGAAATTTCCAAAAGTTGCTTATTGACTGTTTGCAGTTGACAGAGTTTGAGGCTGCGTACAACCAGATTGGGGGTTCAATTGATCCGCATATTGGTGACCATACAATGCTCCAGCGCCTTGATTTGAGGGGGAACAAACTTACTGGATTTCTGCCTGATCAATTGGGAAACCTGAAAGACATCAAATGGTTGCTTTTAGGGGGGAACAATTTAACTGGAGATATCCCTTCTCAACTTGGTCAATTGGCTTCCCTTGTTGTTTTGGATCTATCTCACAATGCTCTTACTGGCACAATTCCTGTAAGCTTGACAAATGCCACAACTCTTGAATCTCTGTTGCTAGATCACAACAAGCTCAATGGGGAAATACCTTCATCCTTTTCCACTCTTTCCAGTCTTGTTGGTTTTGATGTTTCTTTCAACAACCTTTCTGGTCATATTCCCCATCTCCGTAACCAAATTGATTGTGACTCCTTCAAAGGGAATGTACACCTGCATTCATGCCCTGATCCATATTCTGCCTTACCTGCTTATCTCCCAGTCCCTCTTGAAGTCCAAAATTGGCAGAGACGAAAAAAGTTGAAGACAATAATAATAGCTGTGGTCTCTTCAGTCTCTGTGGTCCTCTGTGTACTAGGAATAGTTTTAGTGATCACTTTTGGAAGGAACAAGTTTGGTCGGCTCAGCAGCCTTCGAAGCAGACTACTAGTGACCTTCCAAGATGTTCCCATTGAACTCAATTACGATAATGTTGTCACAGCCACAGGAAATTTCAGCCTCCAAAATCTAATTGGAACCGGTGGGTTTGGGTCTACTTACAAGGCTGAACTATCCCCTCGTTTCCTCGTTGCCATTAAGAGGTTGTCTATAGGTAAATTCCAAGGCATTCAACAGTTCGAGACAGAGATAAGAACCTTGGGGAGAATCCGACACAAAAACCTTGTCACTCTTATTGGCTACTATGTAGGAGAGGCCGAAATGTTCTTGATATACAACTACCTTTCAGGTGGGAACCTTGAAACTTTCATACACAACAATTCAGATAAAAACATGTTGTGGCCAATTATCTACAAGATAGCAATAGACGTGGCAGAGGCCATAGCTTACCTTCACTACTCCTGTGTTCCTCGCATTGTTCATCGTGACATCAAGCCCAGCAACATCTTACTTGATGATGACTACAATGCCTACCTTTCAGATTTTGGATTGGCTAGACTCATGGAGGTATCTGAGACCCACGCCACAACTGATGTGGAAGGCACATTTGGGTATGTTGCACCTGAGTATGCCACCACTTGCAGGGTTTCTGACAAAGCAGATGTTTATAGCTTTGGCGTTGTGTTATTAGAGTTGATGTCTGGAAGGAAGTCACTAGATCCATCGTTTTCTGAATATGGAAACGGGTTCAATATTGTGCCGTGGGCTAAGTTGCTAATGACGGAAGGTCGTTCTTCTGAACTGTTTTCACCTGCTCTGTGGGAAGCAGGACCTGAGGAGAAACTGTTGGGGCTTTTGAAAGTTGCATTAATCTGCACGGTGGAGACGCTTTCCATTCGGCCATCGATGAAACAGGTTCTTGAGAGATTGAGACAACTTAAAAGTTGA | 3126 | 0.4376 | MDLLLGLLLLAFVFLFTAHCSEDIATSVPSDALSLLSFKDSVSSESSALLVGWSKESTESYCQWHGVTCEDRLSGRVIALNLTGLRGGKLTPSIGDMSGLRVLSLPQNTFSGEIPETLGKLRLLEVLELQENNFSGGIPNQISYLPSLRILNLSNNALSGSMPGKLIGFGNVSVMDLSSNQLSGPIVDSVNTVFEFLNHLKLSDNFLTGQIPSEIGKFRNLRTLLLDGNILEGAIPSEIGYMTELRLLDVSRNSLTGRIPKEIANCRKLSVLVLTDLVDDTPSPDESSVNSFRGEFNAFVGNIPPQVMLLSSLEILWAPRANLGGRLPRGWTDSCSLRVVNLAENYIIGGIPETLGMCRNLTFLDLSSNNLVGYLPLKQLQVPCMLYFNVSWNNLSGTLPGFGNESCDLSRILGDAQVDILVWESLMDALPGSGSEDAVVINHDFSWNNFTGSLPLFLLGDTTRSKISYTLSLSNNKFSGTLPYHLVLNCNDFKMLKVNLSVNELSGGNFQKLLIDCLQLTEFEAAYNQIGGSIDPHIGDHTMLQRLDLRGNKLTGFLPDQLGNLKDIKWLLLGGNNLTGDIPSQLGQLASLVVLDLSHNALTGTIPVSLTNATTLESLLLDHNKLNGEIPSSFSTLSSLVGFDVSFNNLSGHIPHLRNQIDCDSFKGNVHLHSCPDPYSALPAYLPVPLEVQNWQRRKKLKTIIIAVVSSVSVVLCVLGIVLVITFGRNKFGRLSSLRSRLLVTFQDVPIELNYDNVVTATGNFSLQNLIGTGGFGSTYKAELSPRFLVAIKRLSIGKFQGIQQFETEIRTLGRIRHKNLVTLIGYYVGEAEMFLIYNYLSGGNLETFIHNNSDKNMLWPIIYKIAIDVAEAIAYLHYSCVPRIVHRDIKPSNILLDDDYNAYLSDFGLARLMEVSETHATTDVEGTFGYVAPEYATTCRVSDKADVYSFGVVLLELMSGRKSLDPSFSEYGNGFNIVPWAKLLMTEGRSSELFSPALWEAGPEEKLLGLLKVALICTVETLSIRPSMKQVLERLRQLKS | 1041 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Pral4691g00105 | 1041 | CDD | STKc_IRAK | 771 | 1039 | - | - | |
Pral4691g00105 | 1041 | Gene3D | Ribonuclease Inhibitor | 291 | 415 | IPR032675 | - | |
Pral4691g00105 | 1041 | Gene3D | Ribonuclease Inhibitor | 437 | 676 | IPR032675 | - | |
Pral4691g00105 | 1041 | ProSiteProfiles | Leucine-rich repeat profile. | 360 | 381 | IPR001611 | GO:0005515 | |
Pral4691g00105 | 1041 | Gene3D | Transferase(Phosphotransferase) domain 1 | 841 | 1040 | - | - | |
Pral4691g00105 | 1041 | SUPERFAMILY | Protein kinase-like (PK-like) | 743 | 1036 | IPR011009 | - | |
Pral4691g00105 | 1041 | PANTHER | LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED | 296 | 1038 | - | - | |
Pral4691g00105 | 1041 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 885 | 897 | IPR008271 | GO:0004672|GO:0006468 | |
Pral4691g00105 | 1041 | ProSitePatterns | Protein kinases ATP-binding region signature. | 771 | 799 | IPR017441 | GO:0005524 | |
Pral4691g00105 | 1041 | FunFam | LRR receptor-like serine/threonine-protein kinase RPK2 | 841 | 1041 | - | - | |
Pral4691g00105 | 1041 | SMART | serkin_6 | 765 | 1040 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Pral4691g00105 | 1041 | Pfam | Leucine rich repeat N-terminal domain | 29 | 69 | IPR013210 | - | |
Pral4691g00105 | 1041 | Pfam | Protein kinase domain | 767 | 966 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Pral4691g00105 | 1041 | SMART | LRR_typ_2 | 145 | 168 | IPR003591 | - | |
Pral4691g00105 | 1041 | SMART | LRR_typ_2 | 542 | 564 | IPR003591 | - | |
Pral4691g00105 | 1041 | SMART | LRR_typ_2 | 242 | 266 | IPR003591 | - | |
Pral4691g00105 | 1041 | SMART | LRR_typ_2 | 589 | 613 | IPR003591 | - | |
Pral4691g00105 | 1041 | FunFam | LRR receptor-like serine/threonine-protein kinase GSO1 | 424 | 681 | - | - | |
Pral4691g00105 | 1041 | SUPERFAMILY | RNI-like | 81 | 398 | - | - | |
Pral4691g00105 | 1041 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 192 | 277 | - | - | |
Pral4691g00105 | 1041 | SUPERFAMILY | L domain-like | 467 | 656 | - | - | |
Pral4691g00105 | 1041 | FunFam | Leucine-rich repeat receptor-like protein kinase | 28 | 188 | - | - | |
Pral4691g00105 | 1041 | Pfam | Leucine rich repeat | 544 | 602 | IPR001611 | GO:0005515 | |
Pral4691g00105 | 1041 | Pfam | Leucine rich repeat | 124 | 182 | IPR001611 | GO:0005515 | |
Pral4691g00105 | 1041 | ProSiteProfiles | Protein kinase domain profile. | 765 | 1041 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Pral4691g00105 | 1041 | PRINTS | Leucine-rich repeat signature | 589 | 602 | - | - | |
Pral4691g00105 | 1041 | PRINTS | Leucine-rich repeat signature | 361 | 374 | - | - | |
Pral4691g00105 | 1041 | FunFam | LRR receptor-like serine/threonine-protein kinase RPK2 | 729 | 840 | - | - | |
Pral4691g00105 | 1041 | Gene3D | Ribonuclease Inhibitor | 30 | 193 | IPR032675 | - | |
Pral4691g00105 | 1041 | Gene3D | Ribonuclease Inhibitor | 194 | 290 | IPR032675 | - | |
Pral4691g00105 | 1041 | Gene3D | Phosphorylase Kinase; domain 1 | 729 | 840 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Pral4691g00105 | Pral-Chr4691 | 1124558 | 1128348 | Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Pral4691g00105 | 2 | 1040 | Receptor kinase-like Gene Family | AT3G02130 | 43.913 | 0.0 | 802 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XV | Pral4691g00105 | Pkinase | 9e-41 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Pral4691g00105 | - | - | gmx:100795047 | 1399.03 |